跳至主要内容
临床试验/ITMCTR2200006783
ITMCTR2200006783尚未招募1 期

Pre-study of acupuncture for postmenopausal osteoporosis

Wangjing Hospital of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
45 至 70(—)
性别
Female

入选标准

  • (1)Meets diagnostic criteria for postmenopausal osteoporosis
  • (2)Patients with postmenopausal osteoporosis between the ages of 45 (inclusive) and 70 (exclusive)
  • (3)Baseline VAS = 4 points and VAS < 7 points
  • (4)Voluntary participation in this clinical study, signed informed consent form

排除标准

  • (1)Secondary osteoporosis or history of osteoporotic fracture within the last 1 year
  • (2)Combined with rheumatoid arthritis, osteoarthritis, diabetes, gastrointestinal diseases, etc.
  • (3)Severe cardiac, hepatic, renal and other organ insufficiencies, hematologic and autoimmune diseases, acute and chronic infections, malignant tumors, or serious mental illnesses
  • (4)History of thyroid, pituitary, hypothalamus and other endocrine disorders
  • (5)Use of zoledronate within the last 1 year, use of disulfiramab within the last 6 months, oral bisphosphonates Salt, anti-osteoporosis herbal preparations such as bone care capsule, Jin Tian Ge capsule, etc. discontinued for less than 3 months
  • (6)Year-round use of hormones such as glucocorticoids, sex hormones, active vitamin D, fluoride, anti-seizure epileptic drugs, etc.
  • (7)Those unable to cooperate in completing this study

研究者

发起方
Wangjing Hospital of China Academy of Chinese Medical Sciences

相似试验